Blue Jay Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $8.58M | Sell |
94,454
-10,546
| -10% | -$958K | 5.85% | 6 |
|
|
2017
Q1 | $9.22M | Buy |
+105,000
| New | +$9.22M | 4.53% | 13 |
|
|
2016
Q4 | – | Sell |
-137,595
| Closed | -$12.7M | – | 17 |
|
|
2016
Q3 | $12.7M | Sell |
137,595
-14,658
| -10% | -$1.36M | 6.95% | 2 |
|
|
2016
Q2 | $11.8M | Buy |
152,253
+77,253
| +103% | +$6.01M | 7.78% | 4 |
|
|
2016
Q1 | $6.19M | Buy |
+75,000
| New | +$6.19M | 3.96% | 15 |
|
|
2015
Q4 | – | Sell |
-139,164
| Closed | -$14.7M | – | 25 |
|
|
2015
Q3 | $14.7M | Buy |
139,164
+44,499
| +47% | +$4.69M | 5.76% | 5 |
|
|
2015
Q2 | $12.9M | Buy |
94,665
+7,165
| +8% | +$980K | 3.48% | 13 |
|
|
2015
Q1 | $10.9M | Buy |
+87,500
| New | +$10.9M | 3.83% | 20 |
|